nodes	percent_of_prediction	percent_of_DWPC	metapath
Tinidazole—CYP3A4—bone cancer	0.918	1	CbGaD
Tinidazole—Metronidazole—CYP3A4—bone cancer	0.00611	1	CrCbGaD
Tinidazole—Drug hypersensitivity—Epirubicin—bone cancer	0.00135	0.0178	CcSEcCtD
Tinidazole—Drug hypersensitivity—Doxorubicin—bone cancer	0.00125	0.0164	CcSEcCtD
Tinidazole—Body temperature increased—Carboplatin—bone cancer	0.00102	0.0134	CcSEcCtD
Tinidazole—Urine abnormality—Epirubicin—bone cancer	0.000983	0.0129	CcSEcCtD
Tinidazole—Vaginal discharge—Methotrexate—bone cancer	0.000956	0.0126	CcSEcCtD
Tinidazole—Urine analysis abnormal—Epirubicin—bone cancer	0.000926	0.0122	CcSEcCtD
Tinidazole—Urine abnormality—Doxorubicin—bone cancer	0.00091	0.012	CcSEcCtD
Tinidazole—Vaginal discharge—Epirubicin—bone cancer	0.000895	0.0118	CcSEcCtD
Tinidazole—Pelvic pain—Epirubicin—bone cancer	0.000895	0.0118	CcSEcCtD
Tinidazole—Oral candidiasis—Epirubicin—bone cancer	0.000857	0.0113	CcSEcCtD
Tinidazole—Urine analysis abnormal—Doxorubicin—bone cancer	0.000856	0.0113	CcSEcCtD
Tinidazole—Burning sensation—Methotrexate—bone cancer	0.000837	0.011	CcSEcCtD
Tinidazole—Vaginal discharge—Doxorubicin—bone cancer	0.000828	0.0109	CcSEcCtD
Tinidazole—Pelvic pain—Doxorubicin—bone cancer	0.000828	0.0109	CcSEcCtD
Tinidazole—Oral candidiasis—Doxorubicin—bone cancer	0.000793	0.0104	CcSEcCtD
Tinidazole—Burning sensation—Epirubicin—bone cancer	0.000783	0.0103	CcSEcCtD
Tinidazole—Dermatitis atopic—Epirubicin—bone cancer	0.000735	0.00966	CcSEcCtD
Tinidazole—Burning sensation—Doxorubicin—bone cancer	0.000725	0.00952	CcSEcCtD
Tinidazole—Cramp muscle—Cisplatin—bone cancer	0.000693	0.0091	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.000693	0.0091	CcSEcCtD
Tinidazole—Dermatitis atopic—Doxorubicin—bone cancer	0.00068	0.00894	CcSEcCtD
Tinidazole—Glossitis—Methotrexate—bone cancer	0.000631	0.00829	CcSEcCtD
Tinidazole—Glossitis—Epirubicin—bone cancer	0.000591	0.00776	CcSEcCtD
Tinidazole—Neuropathy peripheral—Cisplatin—bone cancer	0.000581	0.00764	CcSEcCtD
Tinidazole—Stomatitis—Cisplatin—bone cancer	0.000578	0.00759	CcSEcCtD
Tinidazole—Blood bilirubin increased—Epirubicin—bone cancer	0.000575	0.00756	CcSEcCtD
Tinidazole—Glossitis—Doxorubicin—bone cancer	0.000546	0.00718	CcSEcCtD
Tinidazole—Blood bilirubin increased—Doxorubicin—bone cancer	0.000532	0.007	CcSEcCtD
Tinidazole—Coma—Methotrexate—bone cancer	0.000531	0.00698	CcSEcCtD
Tinidazole—Salivary hypersecretion—Epirubicin—bone cancer	0.000529	0.00694	CcSEcCtD
Tinidazole—Urinary tract disorder—Cisplatin—bone cancer	0.000526	0.00691	CcSEcCtD
Tinidazole—Urethral disorder—Cisplatin—bone cancer	0.000522	0.00685	CcSEcCtD
Tinidazole—Candida infection—Epirubicin—bone cancer	0.00052	0.00683	CcSEcCtD
Tinidazole—Blood urea increased—Epirubicin—bone cancer	0.000514	0.00675	CcSEcCtD
Tinidazole—Coma—Epirubicin—bone cancer	0.000497	0.00653	CcSEcCtD
Tinidazole—Flushing—Cisplatin—bone cancer	0.000494	0.00649	CcSEcCtD
Tinidazole—Salivary hypersecretion—Doxorubicin—bone cancer	0.000489	0.00643	CcSEcCtD
Tinidazole—Candida infection—Doxorubicin—bone cancer	0.000481	0.00632	CcSEcCtD
Tinidazole—Immune system disorder—Cisplatin—bone cancer	0.000481	0.00632	CcSEcCtD
Tinidazole—Blood urea increased—Doxorubicin—bone cancer	0.000475	0.00625	CcSEcCtD
Tinidazole—Malnutrition—Cisplatin—bone cancer	0.000463	0.00609	CcSEcCtD
Tinidazole—Coma—Doxorubicin—bone cancer	0.00046	0.00605	CcSEcCtD
Tinidazole—Flatulence—Cisplatin—bone cancer	0.000457	0.006	CcSEcCtD
Tinidazole—Muscle spasms—Cisplatin—bone cancer	0.000445	0.00585	CcSEcCtD
Tinidazole—Ill-defined disorder—Cisplatin—bone cancer	0.00043	0.00565	CcSEcCtD
Tinidazole—Malaise—Cisplatin—bone cancer	0.000418	0.00549	CcSEcCtD
Tinidazole—Leukopenia—Cisplatin—bone cancer	0.000415	0.00545	CcSEcCtD
Tinidazole—Convulsion—Cisplatin—bone cancer	0.000401	0.00527	CcSEcCtD
Tinidazole—Ataxia—Methotrexate—bone cancer	0.000397	0.00522	CcSEcCtD
Tinidazole—Myalgia—Cisplatin—bone cancer	0.000394	0.00518	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000392	0.00515	CcSEcCtD
Tinidazole—Discomfort—Cisplatin—bone cancer	0.00039	0.00512	CcSEcCtD
Tinidazole—Ataxia—Epirubicin—bone cancer	0.000371	0.00488	CcSEcCtD
Tinidazole—Nervous system disorder—Cisplatin—bone cancer	0.000371	0.00487	CcSEcCtD
Tinidazole—Thrombocytopenia—Cisplatin—bone cancer	0.00037	0.00486	CcSEcCtD
Tinidazole—Skin disorder—Cisplatin—bone cancer	0.000367	0.00483	CcSEcCtD
Tinidazole—Hyperhidrosis—Cisplatin—bone cancer	0.000366	0.0048	CcSEcCtD
Tinidazole—Anorexia—Cisplatin—bone cancer	0.00036	0.00474	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.000356	0.00467	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000344	0.00453	CcSEcCtD
Tinidazole—Ataxia—Doxorubicin—bone cancer	0.000344	0.00452	CcSEcCtD
Tinidazole—Neutropenia—Methotrexate—bone cancer	0.000341	0.00448	CcSEcCtD
Tinidazole—Dysuria—Methotrexate—bone cancer	0.000341	0.00448	CcSEcCtD
Tinidazole—Paraesthesia—Cisplatin—bone cancer	0.00034	0.00446	CcSEcCtD
Tinidazole—Dyspnoea—Cisplatin—bone cancer	0.000337	0.00443	CcSEcCtD
Tinidazole—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.000329	0.00433	CcSEcCtD
Tinidazole—Decreased appetite—Cisplatin—bone cancer	0.000329	0.00432	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Cisplatin—bone cancer	0.000326	0.00429	CcSEcCtD
Tinidazole—Drowsiness—Methotrexate—bone cancer	0.000325	0.00427	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000323	0.00424	CcSEcCtD
Tinidazole—Neutropenia—Epirubicin—bone cancer	0.000319	0.0042	CcSEcCtD
Tinidazole—Dysuria—Epirubicin—bone cancer	0.000319	0.0042	CcSEcCtD
Tinidazole—Stomatitis—Methotrexate—bone cancer	0.000317	0.00417	CcSEcCtD
Tinidazole—Sweating—Methotrexate—bone cancer	0.000312	0.0041	CcSEcCtD
Tinidazole—Feeling abnormal—Cisplatin—bone cancer	0.000312	0.00409	CcSEcCtD
Tinidazole—Drowsiness—Epirubicin—bone cancer	0.000304	0.004	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000302	0.00397	CcSEcCtD
Tinidazole—Body temperature increased—Cisplatin—bone cancer	0.000299	0.00393	CcSEcCtD
Tinidazole—Neuropathy peripheral—Epirubicin—bone cancer	0.000298	0.00392	CcSEcCtD
Tinidazole—Stomatitis—Epirubicin—bone cancer	0.000297	0.0039	CcSEcCtD
Tinidazole—Urinary tract infection—Epirubicin—bone cancer	0.000296	0.00389	CcSEcCtD
Tinidazole—Dysuria—Doxorubicin—bone cancer	0.000295	0.00388	CcSEcCtD
Tinidazole—Neutropenia—Doxorubicin—bone cancer	0.000295	0.00388	CcSEcCtD
Tinidazole—Sweating—Epirubicin—bone cancer	0.000292	0.00383	CcSEcCtD
Tinidazole—Pharyngitis—Methotrexate—bone cancer	0.00029	0.00381	CcSEcCtD
Tinidazole—Urinary tract disorder—Methotrexate—bone cancer	0.000288	0.00379	CcSEcCtD
Tinidazole—Urethral disorder—Methotrexate—bone cancer	0.000286	0.00376	CcSEcCtD
Tinidazole—Drowsiness—Doxorubicin—bone cancer	0.000282	0.0037	CcSEcCtD
Tinidazole—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000279	0.00367	CcSEcCtD
Tinidazole—Hypersensitivity—Cisplatin—bone cancer	0.000279	0.00366	CcSEcCtD
Tinidazole—Erythema multiforme—Methotrexate—bone cancer	0.000276	0.00363	CcSEcCtD
Tinidazole—Neuropathy peripheral—Doxorubicin—bone cancer	0.000276	0.00363	CcSEcCtD
Tinidazole—Stomatitis—Doxorubicin—bone cancer	0.000275	0.00361	CcSEcCtD
Tinidazole—Urinary tract infection—Doxorubicin—bone cancer	0.000274	0.0036	CcSEcCtD
Tinidazole—Hypoaesthesia—Epirubicin—bone cancer	0.000272	0.00357	CcSEcCtD
Tinidazole—Asthenia—Cisplatin—bone cancer	0.000271	0.00356	CcSEcCtD
Tinidazole—Pharyngitis—Epirubicin—bone cancer	0.000271	0.00356	CcSEcCtD
Tinidazole—Sweating—Doxorubicin—bone cancer	0.00027	0.00355	CcSEcCtD
Tinidazole—Urinary tract disorder—Epirubicin—bone cancer	0.00027	0.00355	CcSEcCtD
Tinidazole—Urethral disorder—Epirubicin—bone cancer	0.000268	0.00352	CcSEcCtD
Tinidazole—Angiopathy—Methotrexate—bone cancer	0.000265	0.00348	CcSEcCtD
Tinidazole—Immune system disorder—Methotrexate—bone cancer	0.000264	0.00347	CcSEcCtD
Tinidazole—Diarrhoea—Cisplatin—bone cancer	0.000259	0.0034	CcSEcCtD
Tinidazole—Erythema multiforme—Epirubicin—bone cancer	0.000258	0.0034	CcSEcCtD
Tinidazole—Malnutrition—Methotrexate—bone cancer	0.000254	0.00334	CcSEcCtD
Tinidazole—Flushing—Epirubicin—bone cancer	0.000254	0.00333	CcSEcCtD
Tinidazole—Hypoaesthesia—Doxorubicin—bone cancer	0.000252	0.00331	CcSEcCtD
Tinidazole—Pharyngitis—Doxorubicin—bone cancer	0.000251	0.0033	CcSEcCtD
Tinidazole—Urinary tract disorder—Doxorubicin—bone cancer	0.00025	0.00328	CcSEcCtD
Tinidazole—Dysgeusia—Methotrexate—bone cancer	0.000249	0.00327	CcSEcCtD
Tinidazole—Angiopathy—Epirubicin—bone cancer	0.000248	0.00326	CcSEcCtD
Tinidazole—Urethral disorder—Doxorubicin—bone cancer	0.000248	0.00326	CcSEcCtD
Tinidazole—Immune system disorder—Epirubicin—bone cancer	0.000247	0.00324	CcSEcCtD
Tinidazole—Vomiting—Cisplatin—bone cancer	0.00024	0.00316	CcSEcCtD
Tinidazole—Erythema multiforme—Doxorubicin—bone cancer	0.000239	0.00314	CcSEcCtD
Tinidazole—Rash—Cisplatin—bone cancer	0.000238	0.00313	CcSEcCtD
Tinidazole—Dermatitis—Cisplatin—bone cancer	0.000238	0.00313	CcSEcCtD
Tinidazole—Malnutrition—Epirubicin—bone cancer	0.000238	0.00313	CcSEcCtD
Tinidazole—Ill-defined disorder—Methotrexate—bone cancer	0.000236	0.0031	CcSEcCtD
Tinidazole—Flushing—Doxorubicin—bone cancer	0.000235	0.00308	CcSEcCtD
Tinidazole—Flatulence—Epirubicin—bone cancer	0.000234	0.00308	CcSEcCtD
Tinidazole—Dysgeusia—Epirubicin—bone cancer	0.000233	0.00306	CcSEcCtD
Tinidazole—Angiopathy—Doxorubicin—bone cancer	0.000229	0.00301	CcSEcCtD
Tinidazole—Malaise—Methotrexate—bone cancer	0.000229	0.00301	CcSEcCtD
Tinidazole—Muscle spasms—Epirubicin—bone cancer	0.000229	0.00301	CcSEcCtD
Tinidazole—Immune system disorder—Doxorubicin—bone cancer	0.000228	0.003	CcSEcCtD
Tinidazole—Vertigo—Methotrexate—bone cancer	0.000228	0.003	CcSEcCtD
Tinidazole—Leukopenia—Methotrexate—bone cancer	0.000228	0.00299	CcSEcCtD
Tinidazole—Nausea—Cisplatin—bone cancer	0.000225	0.00295	CcSEcCtD
Tinidazole—Ill-defined disorder—Epirubicin—bone cancer	0.000221	0.0029	CcSEcCtD
Tinidazole—Convulsion—Methotrexate—bone cancer	0.00022	0.00289	CcSEcCtD
Tinidazole—Malnutrition—Doxorubicin—bone cancer	0.00022	0.00289	CcSEcCtD
Tinidazole—Flatulence—Doxorubicin—bone cancer	0.000217	0.00285	CcSEcCtD
Tinidazole—Arthralgia—Methotrexate—bone cancer	0.000216	0.00284	CcSEcCtD
Tinidazole—Myalgia—Methotrexate—bone cancer	0.000216	0.00284	CcSEcCtD
Tinidazole—Dysgeusia—Doxorubicin—bone cancer	0.000216	0.00283	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000215	0.00282	CcSEcCtD
Tinidazole—Malaise—Epirubicin—bone cancer	0.000215	0.00282	CcSEcCtD
Tinidazole—Discomfort—Methotrexate—bone cancer	0.000214	0.00281	CcSEcCtD
Tinidazole—Vertigo—Epirubicin—bone cancer	0.000214	0.00281	CcSEcCtD
Tinidazole—Leukopenia—Epirubicin—bone cancer	0.000213	0.0028	CcSEcCtD
Tinidazole—Muscle spasms—Doxorubicin—bone cancer	0.000212	0.00278	CcSEcCtD
Tinidazole—Palpitations—Epirubicin—bone cancer	0.00021	0.00276	CcSEcCtD
Tinidazole—Confusional state—Methotrexate—bone cancer	0.000209	0.00275	CcSEcCtD
Tinidazole—Convulsion—Epirubicin—bone cancer	0.000206	0.00271	CcSEcCtD
Tinidazole—Ill-defined disorder—Doxorubicin—bone cancer	0.000204	0.00268	CcSEcCtD
Tinidazole—Nervous system disorder—Methotrexate—bone cancer	0.000203	0.00267	CcSEcCtD
Tinidazole—Thrombocytopenia—Methotrexate—bone cancer	0.000203	0.00267	CcSEcCtD
Tinidazole—Arthralgia—Epirubicin—bone cancer	0.000203	0.00266	CcSEcCtD
Tinidazole—Myalgia—Epirubicin—bone cancer	0.000203	0.00266	CcSEcCtD
Tinidazole—Skin disorder—Methotrexate—bone cancer	0.000202	0.00265	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000201	0.00264	CcSEcCtD
Tinidazole—Hyperhidrosis—Methotrexate—bone cancer	0.000201	0.00264	CcSEcCtD
Tinidazole—Discomfort—Epirubicin—bone cancer	0.0002	0.00263	CcSEcCtD
Tinidazole—Malaise—Doxorubicin—bone cancer	0.000199	0.00261	CcSEcCtD
Tinidazole—Vertigo—Doxorubicin—bone cancer	0.000198	0.0026	CcSEcCtD
Tinidazole—Anorexia—Methotrexate—bone cancer	0.000198	0.0026	CcSEcCtD
Tinidazole—Leukopenia—Doxorubicin—bone cancer	0.000197	0.00259	CcSEcCtD
Tinidazole—Confusional state—Epirubicin—bone cancer	0.000196	0.00257	CcSEcCtD
Tinidazole—Palpitations—Doxorubicin—bone cancer	0.000195	0.00256	CcSEcCtD
Tinidazole—Convulsion—Doxorubicin—bone cancer	0.000191	0.00251	CcSEcCtD
Tinidazole—Nervous system disorder—Epirubicin—bone cancer	0.00019	0.0025	CcSEcCtD
Tinidazole—Thrombocytopenia—Epirubicin—bone cancer	0.00019	0.0025	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000189	0.00248	CcSEcCtD
Tinidazole—Skin disorder—Epirubicin—bone cancer	0.000189	0.00248	CcSEcCtD
Tinidazole—Hyperhidrosis—Epirubicin—bone cancer	0.000188	0.00247	CcSEcCtD
Tinidazole—Insomnia—Methotrexate—bone cancer	0.000188	0.00247	CcSEcCtD
Tinidazole—Arthralgia—Doxorubicin—bone cancer	0.000187	0.00246	CcSEcCtD
Tinidazole—Myalgia—Doxorubicin—bone cancer	0.000187	0.00246	CcSEcCtD
Tinidazole—Paraesthesia—Methotrexate—bone cancer	0.000186	0.00245	CcSEcCtD
Tinidazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000186	0.00245	CcSEcCtD
Tinidazole—Discomfort—Doxorubicin—bone cancer	0.000185	0.00243	CcSEcCtD
Tinidazole—Anorexia—Epirubicin—bone cancer	0.000185	0.00243	CcSEcCtD
Tinidazole—Dyspnoea—Methotrexate—bone cancer	0.000185	0.00243	CcSEcCtD
Tinidazole—Somnolence—Methotrexate—bone cancer	0.000184	0.00242	CcSEcCtD
Tinidazole—Dyspepsia—Methotrexate—bone cancer	0.000183	0.0024	CcSEcCtD
Tinidazole—Confusional state—Doxorubicin—bone cancer	0.000181	0.00238	CcSEcCtD
Tinidazole—Decreased appetite—Methotrexate—bone cancer	0.00018	0.00237	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Methotrexate—bone cancer	0.000179	0.00235	CcSEcCtD
Tinidazole—Fatigue—Methotrexate—bone cancer	0.000179	0.00235	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000177	0.00232	CcSEcCtD
Tinidazole—Nervous system disorder—Doxorubicin—bone cancer	0.000176	0.00232	CcSEcCtD
Tinidazole—Thrombocytopenia—Doxorubicin—bone cancer	0.000176	0.00231	CcSEcCtD
Tinidazole—Insomnia—Epirubicin—bone cancer	0.000176	0.00231	CcSEcCtD
Tinidazole—Skin disorder—Doxorubicin—bone cancer	0.000175	0.00229	CcSEcCtD
Tinidazole—Paraesthesia—Epirubicin—bone cancer	0.000174	0.00229	CcSEcCtD
Tinidazole—Hyperhidrosis—Doxorubicin—bone cancer	0.000174	0.00228	CcSEcCtD
Tinidazole—Dyspnoea—Epirubicin—bone cancer	0.000173	0.00227	CcSEcCtD
Tinidazole—Somnolence—Epirubicin—bone cancer	0.000173	0.00227	CcSEcCtD
Tinidazole—Anorexia—Doxorubicin—bone cancer	0.000171	0.00225	CcSEcCtD
Tinidazole—Feeling abnormal—Methotrexate—bone cancer	0.000171	0.00225	CcSEcCtD
Tinidazole—Dyspepsia—Epirubicin—bone cancer	0.000171	0.00225	CcSEcCtD
Tinidazole—Gastrointestinal pain—Methotrexate—bone cancer	0.00017	0.00223	CcSEcCtD
Tinidazole—Decreased appetite—Epirubicin—bone cancer	0.000169	0.00222	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Epirubicin—bone cancer	0.000168	0.0022	CcSEcCtD
Tinidazole—Fatigue—Epirubicin—bone cancer	0.000167	0.0022	CcSEcCtD
Tinidazole—Constipation—Epirubicin—bone cancer	0.000166	0.00218	CcSEcCtD
Tinidazole—Urticaria—Methotrexate—bone cancer	0.000165	0.00217	CcSEcCtD
Tinidazole—Body temperature increased—Methotrexate—bone cancer	0.000164	0.00216	CcSEcCtD
Tinidazole—Abdominal pain—Methotrexate—bone cancer	0.000164	0.00216	CcSEcCtD
Tinidazole—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000164	0.00215	CcSEcCtD
Tinidazole—Insomnia—Doxorubicin—bone cancer	0.000163	0.00214	CcSEcCtD
Tinidazole—Paraesthesia—Doxorubicin—bone cancer	0.000161	0.00212	CcSEcCtD
Tinidazole—Dyspnoea—Doxorubicin—bone cancer	0.00016	0.0021	CcSEcCtD
Tinidazole—Feeling abnormal—Epirubicin—bone cancer	0.00016	0.0021	CcSEcCtD
Tinidazole—Somnolence—Doxorubicin—bone cancer	0.00016	0.0021	CcSEcCtD
Tinidazole—Gastrointestinal pain—Epirubicin—bone cancer	0.000159	0.00209	CcSEcCtD
Tinidazole—Dyspepsia—Doxorubicin—bone cancer	0.000158	0.00208	CcSEcCtD
Tinidazole—Decreased appetite—Doxorubicin—bone cancer	0.000156	0.00205	CcSEcCtD
Tinidazole—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000155	0.00204	CcSEcCtD
Tinidazole—Fatigue—Doxorubicin—bone cancer	0.000155	0.00204	CcSEcCtD
Tinidazole—Urticaria—Epirubicin—bone cancer	0.000154	0.00203	CcSEcCtD
Tinidazole—Constipation—Doxorubicin—bone cancer	0.000154	0.00202	CcSEcCtD
Tinidazole—Abdominal pain—Epirubicin—bone cancer	0.000154	0.00202	CcSEcCtD
Tinidazole—Body temperature increased—Epirubicin—bone cancer	0.000154	0.00202	CcSEcCtD
Tinidazole—Hypersensitivity—Methotrexate—bone cancer	0.000153	0.00201	CcSEcCtD
Tinidazole—Asthenia—Methotrexate—bone cancer	0.000149	0.00196	CcSEcCtD
Tinidazole—Feeling abnormal—Doxorubicin—bone cancer	0.000148	0.00195	CcSEcCtD
Tinidazole—Gastrointestinal pain—Doxorubicin—bone cancer	0.000147	0.00193	CcSEcCtD
Tinidazole—Pruritus—Methotrexate—bone cancer	0.000147	0.00193	CcSEcCtD
Tinidazole—Hypersensitivity—Epirubicin—bone cancer	0.000143	0.00188	CcSEcCtD
Tinidazole—Urticaria—Doxorubicin—bone cancer	0.000143	0.00188	CcSEcCtD
Tinidazole—Abdominal pain—Doxorubicin—bone cancer	0.000142	0.00187	CcSEcCtD
Tinidazole—Body temperature increased—Doxorubicin—bone cancer	0.000142	0.00187	CcSEcCtD
Tinidazole—Diarrhoea—Methotrexate—bone cancer	0.000142	0.00187	CcSEcCtD
Tinidazole—Asthenia—Epirubicin—bone cancer	0.000139	0.00183	CcSEcCtD
Tinidazole—Pruritus—Epirubicin—bone cancer	0.000137	0.00181	CcSEcCtD
Tinidazole—Dizziness—Methotrexate—bone cancer	0.000137	0.0018	CcSEcCtD
Tinidazole—Diarrhoea—Epirubicin—bone cancer	0.000133	0.00175	CcSEcCtD
Tinidazole—Hypersensitivity—Doxorubicin—bone cancer	0.000132	0.00174	CcSEcCtD
Tinidazole—Vomiting—Methotrexate—bone cancer	0.000132	0.00173	CcSEcCtD
Tinidazole—Rash—Methotrexate—bone cancer	0.000131	0.00172	CcSEcCtD
Tinidazole—Dermatitis—Methotrexate—bone cancer	0.000131	0.00172	CcSEcCtD
Tinidazole—Headache—Methotrexate—bone cancer	0.00013	0.00171	CcSEcCtD
Tinidazole—Asthenia—Doxorubicin—bone cancer	0.000129	0.00169	CcSEcCtD
Tinidazole—Dizziness—Epirubicin—bone cancer	0.000128	0.00169	CcSEcCtD
Tinidazole—Pruritus—Doxorubicin—bone cancer	0.000127	0.00167	CcSEcCtD
Tinidazole—Vomiting—Epirubicin—bone cancer	0.000123	0.00162	CcSEcCtD
Tinidazole—Nausea—Methotrexate—bone cancer	0.000123	0.00162	CcSEcCtD
Tinidazole—Diarrhoea—Doxorubicin—bone cancer	0.000123	0.00162	CcSEcCtD
Tinidazole—Rash—Epirubicin—bone cancer	0.000122	0.00161	CcSEcCtD
Tinidazole—Dermatitis—Epirubicin—bone cancer	0.000122	0.00161	CcSEcCtD
Tinidazole—Headache—Epirubicin—bone cancer	0.000122	0.0016	CcSEcCtD
Tinidazole—Dizziness—Doxorubicin—bone cancer	0.000119	0.00156	CcSEcCtD
Tinidazole—Nausea—Epirubicin—bone cancer	0.000115	0.00152	CcSEcCtD
Tinidazole—Vomiting—Doxorubicin—bone cancer	0.000114	0.0015	CcSEcCtD
Tinidazole—Rash—Doxorubicin—bone cancer	0.000113	0.00149	CcSEcCtD
Tinidazole—Dermatitis—Doxorubicin—bone cancer	0.000113	0.00149	CcSEcCtD
Tinidazole—Headache—Doxorubicin—bone cancer	0.000113	0.00148	CcSEcCtD
Tinidazole—Nausea—Doxorubicin—bone cancer	0.000107	0.0014	CcSEcCtD
